Ono Pharmaceutical Co.-Un ADROPHLY
13F holders, Q2 2026 (June 30)6holders
0new positions
0sold out
$4.86avg. 13F price*
At the end of Q2 2026, 6 institutions reported holding Ono Pharmaceutical Co.-Un ADR (OPHLY) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holders were GAMMA Investing LLC ($221K), Fulton Bank, N.A. ($67K) and First Command Advisory Services, Inc. ($34K).
- Company
- Ono Pharmaceutical Co.-Un ADR
- CUSIP
- 682736103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 5,292 shares bought and 3,831 shares sold, net +1,461 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| GAMMA Investing LLC | 0.01% | Reduce -6.3% | 45,527 | $221K |
| Fulton Bank, N.A. | 0.00% | No change | 13,604 | $67K |
| First Command Advisory Services, Inc. | 0.00% | Add +303.1% | 7,038 | $34K |
| Rhumbline Advisers | 0.00% | Reduce -14.2% | 4,785 | $23K |
| Westside Investment Management, Inc. | 0.00% | No change | 3,747 | $18K |
| Salomon & Ludwin, LLC | 0.00% | Reduce -3.2% | 30 | $145 |
"% of holder's portfolio" is OPHLY's weight in each manager's 13F, not the share of Ono Pharmaceutical Co.-Un ADR the manager owns.